Paper34598
Characterization of the purified NADPH-flavin reductase of human erythrocytes.
Yubisui T and 3 others. J Biochem, 1979. Cited by 48 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Characterization of the purified NADPH-flavin reductase of human erythrocytes. Papers, record 34598. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34598
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Erythrocytes | Major topic |
| NADH, NADPH Oxidoreductases | Major topic |
| Flavin Mononucleotide | |
| Flavins | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Methemoglobin | |
| Molecular Weight | |
| NADP | |
| NADPH Dehydrogenase | |
| Osmolar Concentration | |
| Oxygen |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,543,799 | The UFM1 system regulates ER-phagy through the ufmylation of CYB5R3. | Nat Commun | 2022 | https://conductscience.org/library/papers/36543799 | PubMed |
| 29,487,133 | In silico and crystallographic studies identify key structural features of biliverdin IXβ reductase inhibitors having nanomolar potency. | J Biol Chem | 2018 | https://conductscience.org/library/papers/29487133 | PubMed |
| 19,701,784 | Differences in coordination states of substituted tyrosine residues and quaternary structures among hemoglobin M probed by resonance Raman spectroscopy. | J Biol Inorg Chem | 2010 | https://conductscience.org/library/papers/19701784 | PubMed |
| 8,687,377 | Evidence that biliverdin-IX beta reductase and flavin reductase are identical. | Biochem J | 1996 | https://conductscience.org/library/papers/8687377 | PubMed |
| 8,206,832 | Vibrio harveyi NADPH-flavin oxidoreductase: cloning, sequencing and overexpression of the gene and purification and characterization of the cloned enzyme. | J Bacteriol | 1994 | https://conductscience.org/library/papers/8206832 | PubMed |
| 8,118,169 | Ferric reductases or flavin reductases? | Biometals | 1994 | https://conductscience.org/library/papers/8118169 | PubMed |
| 7,937,764 | Flavin reductase: sequence of cDNA from bovine liver and tissue distribution. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7937764 | PubMed |
| 7,305,986 | Age-dependent decay of cytochrome b5 and cytochrome b5 reductase in human erythrocytes. | Biochem J | 1981 | https://conductscience.org/library/papers/7305986 | PubMed |
| 2,050,627 | Characterization of the flavin reductase gene (fre) of Escherichia coli and construction of a plasmid for overproduction of the enzyme. | J Bacteriol | 1991 | https://conductscience.org/library/papers/2050627 | PubMed |
| 1,549,573 | Characterization of NADPH-dependent methemoglobin reductase as a heme-binding protein present in erythrocytes and liver. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1549573 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| BLVRB | 645 | PubTator's text mining | https://conductscience.org/library/genes/645 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34598
GET https://conductscience.org/api/papers/v1/34598/authors